<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR89">
 <label>89.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bender</surname>
    <given-names>NK</given-names>
   </name>
   <name>
    <surname>Heilig</surname>
    <given-names>CE</given-names>
   </name>
   <name>
    <surname>Dr√∂ll</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Wohlgemuth</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Armbruster</surname>
    <given-names>F-P</given-names>
   </name>
   <name>
    <surname>Heilig</surname>
    <given-names>B</given-names>
   </name>
  </person-group>
  <article-title>Immunogenicity, efficacy and adverse events of adalimumab in RA patients</article-title>
  <source>Rheumatol Int</source>
  <year>2007</year>
  <volume>27</volume>
  <fpage>269</fpage>
  <lpage>274</lpage>
  <pub-id pub-id-type="doi">10.1007/s00296-006-0183-7</pub-id>
  <?supplied-pmid 17006705?>
  <pub-id pub-id-type="pmid">17006705</pub-id>
 </element-citation>
</ref>
